Clover Health Investments (CLOV) Liabilities and Shareholders Equity (2019 - 2026)

Clover Health Investments (CLOV) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $697.7 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 19.53% year-over-year to $697.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 billion (up 17.09% YoY), and the FY2025 full-year result was $541.0 million, down 6.84% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $697.7 million, up from $541.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.7 billion in Q1 2022 and bottomed at $354.7 million in Q4 2022.
• The 5-year median for Liabilities and Shareholders Equity is $580.7 million (2024), against an average of $838.2 million.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity surged 209.12%; it then plunged 72.48% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $354.7 million in 2022, then surged by 60.87% to $570.7 million in 2023, then climbed by 1.76% to $580.7 million in 2024, then retreated by 6.84% to $541.0 million in 2025, then grew by 28.97% to $697.7 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $697.7 million (Q1 2026), $541.0 million (Q4 2025), and $559.7 million (Q3 2025), per Business Quant data.

Peer Comparison